Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients
Clinical trial NCT05855122 · UNKNOWN
Trial details
- NCT number
- NCT05855122
- Sponsor
- The First Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2024-08-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.